The University of Chicago Cancer Research Foundation (UCCRF) plays a key role in helping the UCCCC enhance cancer care, develop more effective and safer therapies, and promote prevention and screening research. The UCCRF is a not-for-profit organization, founded by Maurice Goldblatt in the 1940s, to support basic and clinical research programs related to the treatment and prevention of cancer at the UCCCC.
UCCRF funding has enabled creative experimentation that tested unconventional ideas and brought about monumental advances in cancer care. It has supported research that deepened and expanded our understanding of malignancy. It also has promoted the value and importance of cancer prevention and research in our communities.
The University of Chicago, a globally recognized institution that has been home to distinguished scientists and Nobel Prize laureates for over a century, has a history of exceptional accomplishments, many of which were funded with the help of the UCCRF. For example:
- UCCCC research discoveries have contributed to the introduction of the majority of cancer treatments used today, including chemotherapy, hormonal therapy, gene therapy, and bone marrow transplantation.
- The UCCCC has pioneered imaging technologies and techniques that have enhanced cancer diagnosis, screening, and prevention.
- The UCCCC is a world leader in the promising new field of pharmacogenomics, which integrates genetics, pharmacology, and medicine to study how an individual's genetic makeup influences his or her response to therapy.
- UCCCC efforts have resulted in new surgical techniques, including minimally invasive surgery, which reduces tissue damage and blood loss.
- The UCCCC is known for breakthrough discoveries underlying the development of many effective drug therapies.
The exceptional research performed at the UCCCC is one reason U.S. News and World Report has ranked our cancer program as one of the top 15 in the nation and the best in Illinois.